18F-PSMA-1007 ZRP >= 40 MBq / mL
7680674040019
CH-67404
V09IX17
17.01.9.
1 / 2
google
Details
- GTIN
- 7680674040019
- Pharmacode
- -
- Product number
- 6740401
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- (18F)PSMA-1007 ≥ 40 MBq, dinatrii phosphas, kalii dihydrogenophosphas, natrii chloridum, kalii chloridum, natrii ascorbas, ethanolum 0.0375 ml, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 4.2 mg.
Articles (1)
18F-PSMA-1007 ZRP ≥ 40 MBq / mL, Injektionslösung
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(18F)-PSMA-1007
|
- | Substance | Wirkstoff (Principe actif) |
|
dinatrii phosphas
|
- | Substance | HNIDK |
|
kalii dihydrogenophosphas
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
kalii chloridum
|
- | Substance | HNIDK |
|
natrii ascorbas
|
- | Substance | HNIDK |
|
ethanolum
|
0.0375 ML | Substance | HBESI |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
4.2 MG | Substance | HBESI |
Authorization holder
Universitätsspital Zürich
8091 Zürich
Authorization information
- Swissmedic authorization number
- 67404
- Drug name
- 18F-PSMA-1007 ZRP, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- V09IX17
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 11/06/2024
- Authorization expiration date
- 10/06/2029
- IT number
- 17.01.9.
- Domain
- Human medicine
Packaging details
- Description (FR)
- 18F-PSMA-1007 ZRP >= 40 MBq / mL
- Description (DE)
- 18F-PSMA-1007 ZRP >= 40 MBq / mL
- Market launch
- 11/06/2024
- Market withdrawal
- 10/06/2029
- Narcotic (BTM)
- No